DBX2:F:F-Xtrackers - MSCI EM Asia Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 46.955

Change

0.00 (0.00)%

Market Cap

USD 0.42B

Volume

442.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.56 (-1.08%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.21 (-0.97%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

+4.46 (+0.89%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.36 (-0.65%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

+0.38 (+0.42%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.85 (-0.36%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.11 (-0.69%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

+0.46 (+0.50%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.73 (+0.81%)

USD 49.95B

ETFs Containing DBX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 2.79% 38% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.79% 37% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain 2.88% 57% F 59% D-
Dividend Return 2.88% 55% F 54% F
Total Return N/A 95% A 99% N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.62% 31% F 65% D
Risk Adjusted Return 17.35% 49% F 53% F
Market Capitalization 0.42B 57% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.